MIM
AXNX

MetLife Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

MetLife Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,422
Closed -$2.05M – 2880
2024
Q3 		$2.05M Hold
29,422
– – 0.01% 1004
2024
Q2 		$1.98M Buy
29,422
+3,841
+15% +$259K 0.01% 977
2024
Q1 		$1.76M Sell
25,581
-614
-2% -$41.4K 0.01% 1007
2023
Q4 		$1.63M Hold
26,195
– – 0.01% 1037
2023
Q3 		$1.47M Hold
26,195
– – 0.01% 1040
2023
Q2 		$1.32M Buy
26,195
+224
+0.9% +$11.9K 0.01% 1118
2023
Q1 		$1.42M Hold
25,971
– – 0.01% 1051
2022
Q4 		$1.62M Hold
25,971
– – 0.01% 991
2022
Q3 		$1.83M Buy
25,971
+1,234
+5% +$85.1K 0.02% 919
2022
Q2 		$1.4M Hold
24,737
– – 0.01% 1048
2022
Q1 		$1.55M Buy
24,737
+8,782
+55% +$473K 0.01% 1101
2021
Q4 		$893K Hold
15,955
– – 0.01% 1177
2021
Q3 		$1.04M Buy
15,955
+942
+6% +$64.3K 0.01% 1103
2021
Q2 		$952K Buy
15,013
+3,367
+29% +$199K 0.01% 1186
2021
Q1 		$697K Sell
11,646
-2,145
-16% -$117K 0.01% 1335
2020
Q4 		$688K Hold
13,791
– – 0.01% 1314
2020
Q3 		$704K Hold
13,791
– – 0.01% 1203
2020
Q2 		$484K Buy
13,791
+6,323
+85% +$218K 0.01% 1397
2020
Q1 		$190K Hold
7,468
– – ﹤0.01% 1729
2019
Q4 		$207K Hold
7,468
– – ﹤0.01% 1961
2019
Q3 		$201K Hold
7,468
– – ﹤0.01% 1942
2019
Q2 		$306K Buy
+7,468
New +$210K ﹤0.01% 1774

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MetLife Investment Management's AXNX Position: Q4 2024 in Review

MetLife Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 29,422 shares — an estimated $2.05M sold.

MetLife Investment Management first reported a position in AXNX in Q2 2019 and held it in 22 quarters. The position peaked at $2.05M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • MetLife Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 29,422 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.05M.
  • MetLife Investment Management first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 22 quarters.
  • MetLife Investment Management's Axonics, Inc. Common Stock position peaked at $2.05M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.